Anlon Healthcare Ltd
Anlon Healthcare Ltd Live Price Chart
Performance
| Previous Close | ₹ 21.84 |
| High | ₹ 24.78 |
| Volume | 145565213 |
| 52W Range | ₹ 10.37 - ₹ 24.78 |
| Open | ₹ 22.68 |
| Low | ₹ 22.11 |
| Market Cap | ₹ 824.91 Cr |
Anlon Healthcare Ltd Technicals
| 20 Day | ₹ 17.715 |
| 50 Day | ₹ 16.222 |
| 100 Day | ₹ 15.314 |
| 200 Day | ₹ 14.442 |
| 20 Day | ₹ 16.936 |
| 50 Day | ₹ 15.682 |
| 100 Day | ₹ 15.112 |
| 200 Day | ₹ 14.098 |
Anlon Healthcare Ltd Fundamentals
| ROCE | 17.633 |
| P/E Ratio | 41.710 |
| P/B Ratio | 5.810 |
| Industry P/E | 5.810 |
| Debt to Equity | 51.202 |
| ROE | 13.256 |
| EPS | 0.550 |
| Dividend Yield | 0.000 |
| Book Value | 3.947 |
| Face Value | 2.000 |
Anlon Healthcare Ltd Financials
| Particulars | Y202603 | Y202503 | Y202403 | Y202303 | Y202203 |
|---|---|---|---|---|---|
| Total Revenue | 176.7526 | 120.4551 | 66.6919 | 113.1199 | 57.5364 |
| Total Expenses | 136.0769 | 93.5669 | 56.9408 | 106.1267 | 57.6441 |
| Profit After Tax | 27.8082 | 20.518 | 9.6571 | 5.82 | -0.1077 |
Anlon Healthcare Ltd Shareholding Pattern
| Promoter Holdings | 52.680 % |
| FIIs | 1.668 % |
| DIIs | 1.223 % |
| MutualFund | 0.000 % |
| Retail | 26.189 % |
| Others - | 18.240 % |
About Anlon Healthcare Ltd
Anlon Healthcare Limited was originally incorporated as 'Anlon Ventures Private Limited', dated November 19, 2013 issued by the RoC. The Company changed the name from 'Anlon Ventures Private Limited' to 'Anlon Healthcare Private Limited' and a fresh Certificate of Incorporation dated May 27, 2015 was issued by the RoC. The status of the Company was subsequently converted to a Public Limited and the name of the Company was changed to 'Anlon Healthcare Limited' dated September 2, 2024 by the RoC. Anlon Healthcare is engaged in manufacturing of Pharma Intermediates and APIs. They are one of the few manufacturers of loxoprofen sodium dihydrate in India, a notable API , widely used in treatment of pain/inflammation association with conditions including rheumatoid arthritis, osteoarthritis, lower back pain, frozen shoulder, neck-shoulder-arm syndrome, tooth pain or after surgery, injury or tooth extraction. It serves as a raw material for pharmaceutical formulations in preparation of various type of Finished Dosage Formula (FDF) such as tablet, capsules, ointment, syrup etc, ingredients in nutraceuticals formulations, personal care products and animal health products. In addition to manufacturing of Pharma Intermediate and APIs in accordance with various domestic and international standards, the Company has recently started undertaking custom manufacturing services for complex or novel chemical compounds. The Company started commercial production of Pharma Intermediate and AP ...
Similar Stocks
| Ambalal Sarabhai Enterprises Ltd Pharmaceuticals | ₹ 39.97 -1.31 (-3.17%) |
| Amrutanjan Health Care Ltd Pharmaceuticals | ₹ 493.80 +2.8 (+0.57%) |
| Astrazeneca Pharma India Ltd Pharmaceuticals | ₹ 6,751.50 +82.5 (+1.24%) |
| Bliss GVS Pharma Ltd Pharmaceuticals | ₹ 681.85 -8.8 (-1.27%) |
| Abbott India Ltd Pharmaceuticals | ₹ 27,270.00 +1360 (+5.25%) |
| Cipla Ltd Pharmaceuticals | ₹ 1,394.50 +18.2 (+1.32%) |
FAQs on Anlon Healthcare Ltd
1. Can I buy Anlon Healthcare Ltd from PL Capital? ›
2. Does Anlon Healthcare Ltd pay dividends? ›
3. What is the current share price of Anlon Healthcare Ltd ? ›
4. What is the 52-week high and low of Anlon Healthcare Ltd ? ›
5. What is the market capitalisation of Anlon Healthcare Ltd? ›
6. What is the current P/E ratio of Anlon Healthcare Ltd? ›
7. What is the current P/B ratio of Anlon Healthcare Ltd? ›
8. What is the shareholding pattern of Anlon Healthcare Ltd? ›
9. What is the 1-year return of Anlon Healthcare Ltd? ›
Start SIP in Anlon Healthcare Ltd
Invest systematically in stocks with the
PL Capital app
Are you a new user? Open your account
